SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689375-22-000004
Filing Date
2022-05-12
Accepted
2022-05-12 07:24:47
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q trda-20220331.htm   iXBRL 10-Q 1420105
2 EX-31.1 trda-20220331x10qex311.htm EX-31.1 10354
3 EX-31.2 trda-20220331x10qex312.htm EX-31.2 10363
4 EX-32.1 trda-20220331x10qex321.htm EX-32.1 7330
10 GRAPH trda-20220331_g1.jpg GRAPHIC 128867
  Complete submission text file 0001689375-22-000004.txt   5468080

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trda-20220331.xsd EX-101.SCH 34224
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trda-20220331_cal.xml EX-101.CAL 52181
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trda-20220331_def.xml EX-101.DEF 119000
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trda-20220331_lab.xml EX-101.LAB 425607
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trda-20220331_pre.xml EX-101.PRE 276178
61 EXTRACTED XBRL INSTANCE DOCUMENT trda-20220331_htm.xml XML 643378
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40969 | Film No.: 22915711
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences